Press Releases

Advanced Search
  • Jan 29, 2020

    DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Monday, February 10, 2020, at 5:00 p.m. Eastern Time. The company...

  • Jan 22, 2020
    Highlights a year of clinical excellence, innovation and community support

    DaVita is closing the decade by highlighting its milestones and achievements from 2019. Javier Rodriguez took the helm as CEO of DaVita Inc. on June 1, 2019. A DaVita teammate for more than 20...

  • Dec 18, 2019
    Dr. Jeffrey Giullian will take the clinical leadership role for DaVita effective Jan. 1, 2020

    DaVita Kidney Care today announced Dr. Jeffrey Giullian as chief medical officer (CMO). Dr. Giullian has most recently led clinical quality and safety efforts as CMO for DaVita Hospital Services,...

  • Nov 5, 2019

    DaVita Inc. (NYSE: DVA) today announced results for the quarter ended September 30, 2019. Third quarter 2019 financial and operational highlights: Consolidated revenues of $2.904 billion....

  • Nov 5, 2019
    DaVita clinical leaders push for innovation through new research

    DaVita Clinical Research (DCR) is set to present 10 research abstracts from company representatives and medical professionals at the American Society of Nephrology (ASN) annual Kidney Week in...

Show 5102550100 per page